Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 174 participants.
Also called NCT01442272
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 174 participants
- Sponsor
- Hospital Universitario de Canarias
- Registry
-
NCT01442272
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Unknown status
Technical summary
Registry record NCT01442272. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2012-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D
- Acronym
- NEFROVID2010
- Condition
- Kidney Failure, Chronic
- Condition
- Disorder of Vitamin D
- Intervention (Drug)
- Hidroferol®
- Intervention (Drug)
- Paricalcitol: Zemplar®
- Intervention (Drug)
- Habitual medication
- Lead sponsor
- Hospital Universitario de Canarias
Record details
- Record id
cardio:ct-nct01442272- Content hash
e55b265873081dc2460c88d6fcafbca3d1120dcaedd140b1b03c1441d83b0d8a